The interaction of PD-L1 with surface PD-1 receptor on T cells leads to inhibition of cancer cell killing 9, 10, whereas the binding of CD47 to surface SIRPα receptor on phagocytes inhibits cancer cell clearance 7, 8, 11. Here, CD47 is linked to cancer.